Oral Glutamine Is Effective for Preventing Oxaliplatin-Induced Neuropathy in Colorectal Cancer Patients
Open Access
- 1 March 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (3), 312-319
- https://doi.org/10.1634/theoncologist.12-3-312
Abstract
Learning Objectives: After completing this course, the reader will be able to: Identify the clinical features of oxaliplatin-induced neuropathy.Discuss the current approaches for managing chemotherapy-induced neuropathy.Explain the rationale for using glutamine in preventing oxaliplatin-induced neuropathy. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
Funding Information
- Taipei Veterans General Hospital (V95S5-005)
This publication has 34 references indexed in Scilit:
- OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR StudyJournal of Clinical Oncology, 2006
- Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II StudyJournal of Clinical Oncology, 2005
- Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium InfusionsClinical Cancer Research, 2004
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon CancerNew England Journal of Medicine, 2004
- XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Prevention of Oxaliplatin-Induced Peripheral Sensory Neuropathy by Carbamazepine in Patients with Advanced Colorectal CancerClinical Colorectal Cancer, 2002
- Acute Oxaliplatin-Induced Peripheral Nerve HyperexcitabilityJournal of Clinical Oncology, 2002
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)European Journal Of Cancer, 1999
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996